[Primary antiphospholipid syndrome in obstetrics. Apropos of 4 cases with fetal survival].
Monastiri
K
K
Centre de Maternité et de Néonatologie de Sousse.
Chaieb
A
A
Skouri
H
H
Slama
A
A
Chebil
S
S
Maaroufi
R
R
Nouira
M
M
Mokni
M
M
Zanina
R
R
Saidi
H
H
Ben Amor
F
F
Bibi
M
M
Mahjoub
T
T
Kortas
M
M
Snoussi
N
N
Khairi
H
H
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000097:blood / Q000188:drug therapy / Q000276:immunology; D001241:Aspirin / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000188:drug therapy / Q000276:immunology
D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D004176:Dipyridamole; D006493:Heparin; D001241:Aspirin; D011241:Prednisone
Le syndrome des antiphospholipides primitif en obstétrique. A propos de quatre observations avec survie foetale.